Click on the link below to jump to the main contents on this page.
Sept 05, 2014
Meiji and Takeda Announce Co-Promotion Agreement for “ROZEREM®” For the Treatment of Insomnia in Japan
July 28, 2014
Ono and Meiji Seika Pharma enter into an agreement on development and commercialization of Limaprost in Thailand and Indonesia
June 11, 2014
Notice Concerning the Acquisition of Medreich Limited (India) by Meiji Seika Pharma Co., Ltd.(PDF:84KB)
July 26, 2013
Meiji Initiates Phase 1 Clinical Trial of Arbekacin Inhalation Solution (ME1100) in the U.S. and Enters into a Licensing Agreement with PARI Pharma for a Customized eFlow
Technology Inhalation Device
Apr 18, 2013
Meiji Initiates Phase 1 Clinical Trial of ME1111 in U.S. for Topical Treatment of Onychomycosis
Message from the President
In compliance with the Pharmaceutical Affairs Act, Meiji Seika Pharma appoints a...
Nov 18, 2014
【Presentation】Financial Results for the First Half of Fiscal Year Ending March 31, 2015(PDF:3164KB)
Nov 11, 2014
Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2015(PDF:284KB)
Nov 05, 2014
Notice Concerning Revisions to Financial Forecasts for the Fiscal Year ending March 31, 2015(PDF:44KB)
Terms and Conditions
Meiji Holdings Co.,Ltd.